26.42% to Target, Oppenheimer Keeps Outperform Rating for Axovant Sciences (AXON) Stock, Spectrum Brands Holdings (SPB)’s Sentiment Is 1.14

June 14, 2017 - By Dolores Ford

Spectrum Brands Holdings, Inc. is a diversified global consumer products company. The company has market cap of $7.76 billion. The Firm makes, markets and/or distributes its products in approximately 160 countries in the North America (NA); Europe, the Middle East and Africa (EMEA); Latin America (LATAM), and Asia-Pacific (APAC) regions. It has a 25.07 P/E ratio. It has five divisions: Global Batteries & Appliances (GBA), Global Pet Supplies (PET), Home and Garden (H&G), Hardware & Home Improvement (HHI) and Global Auto Care (GAC).

Among 7 analysts covering Axovant Sciences (NYSE:AXON), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Axovant Sciences has $35.0 highest and $8 lowest target. $25.86’s average target is 8.70% above currents $23.79 stock price. Axovant Sciences had 8 analyst reports since September 25, 2015 according to SRatingsIntel. Jefferies maintained Axovant Sciences Ltd (NYSE:AXON) rating on Wednesday, April 19. Jefferies has “Buy” rating and $31 target. The firm earned “Outperform” rating on Wednesday, December 7 by Oppenheimer. The firm has “Overweight” rating by Piper Jaffray given on Thursday, October 22. The stock has “Outperform” rating by Leerink Swann on Tuesday, June 7. Piper Jaffray maintained Axovant Sciences Ltd (NYSE:AXON) rating on Thursday, April 13. Piper Jaffray has “Overweight” rating and $32 target. The firm has “Sell” rating by Chardan Capital Markets given on Friday, September 25. The rating was initiated by H.C. Wainwright on Friday, January 8 with “Buy”.

Analysts await Spectrum Brands Holdings, Inc. (NYSE:SPB) to report earnings on July, 27. They expect $1.94 earnings per share, up 12.14% or $0.21 from last year’s $1.73 per share. SPB’s profit will be $113.60M for 17.08 P/E if the $1.94 EPS becomes a reality. After $1.19 actual earnings per share reported by Spectrum Brands Holdings, Inc. for the previous quarter, Wall Street now forecasts 63.03% EPS growth.

Dynamo Internacional Gestao De Recursos Ltda. holds 10.32% of its portfolio in Spectrum Brands Holdings, Inc. for 630,731 shares. Brahman Capital Corp. owns 1.03 million shares or 5.37% of their US portfolio. Moreover, Goodhaven Capital Management Llc has 4.86% invested in the company for 98,470 shares. The California-based Cypress Funds Llc has invested 3.85% in the stock. Oskie Capital Management Llc, a New York-based fund reported 10,218 shares.

Ratings analysis reveals 67% of Spectrum Brands’s analysts are positive. Out of 3 Wall Street analysts rating Spectrum Brands, 2 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $136.74 while the high is $160.0. The stock’s average target of $147.91 is 11.61% above today’s ($132.52) share price. SPB was included in 4 notes of analysts from September 1, 2016. As per Thursday, September 1, the company rating was initiated by Piper Jaffray. The stock of Spectrum Brands Holdings, Inc. (NYSE:SPB) earned “Neutral” rating by Bank of America on Tuesday, January 10. Jefferies maintained it with “Buy” rating and $160.0 target in Thursday, October 13 report.

About 142,267 shares traded. Spectrum Brands Holdings, Inc. (SPB) has risen 10.42% since June 14, 2016 and is uptrending. It has underperformed by 6.28% the S&P500.

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The company has market cap of $2.62 billion. The Firm is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer’s disease and Lewy body dementia. It currently has negative earnings. The Firm intends to develop a pipeline of product candidates to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders.

About 760,447 shares traded or 37.93% up from the average. Axovant Sciences Ltd (NYSE:AXON) has risen 97.46% since June 14, 2016 and is uptrending. It has outperformed by 80.76% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts